Targeting β-transducin repeat-containing protein E3 ubiquitin ligase augments the effects of antitumor drugs on breast cancer cells

Keyphrases

• Breast Cancer Cells 100%
• Anticancer Drugs 100%
• E3 Ubiquitin Ligase 100%
• Transducin 100%
• Signal Transduction 50%
• Human Breast Cancer Cells 50%
• Dominant Negative 50%
• Doxorubicin 50%
• Cancer Cells 50%
• Paclitaxel 50%
• Nuclear factor-B 50%
• Antiproliferative Activity 50%
• Transcriptional Activity 50%
• Human Breast Cancer 50%
• Anticancer Therapy 50%
• Mammary Tumor Cells 50%
• RNAi Approach 50%
• Forced Expression 50%
• Substrate Recognition 50%
• Control Stability 50%

Biochemistry, Genetics and Molecular Biology

• Cancer Cell 100%
• Ubiquitin-Conjugating Enzyme 100%
• Transducin 100%
• Anticancer 66%
• Signal Transduction 33%
• RNA Interference 33%
• Doxorubicin 33%
• Cell Cycle 33%
• Antiproliferative Activity 33%
• Complement Factor B 33%